10th May 2006 15:43
Allergy Therapeutics PLC10 May 2006 Allergy Therapeutics plc Director Shareholding 10 May 2006 Allergy Therapeutics plc ("the Company") announces that, on 8th May 2006, a USGrantor Retained Annuity Trust (called the "Ignace Goethals GRAT 2001"), ofwhich Ignace Goethals was a Trustee, matured in favour of Mr. Goethals' threechildren, each of whom is over 18. Mr. Goethals held 788,457 shares through thisvehicle since the Company's admission to AIM in 2004. As a consequence, Mr. Goethals' ongoing beneficial holding of shares of 0.1penceeach in the Company, which include 719,349 shares held through another GRAT(called "the Ignace Goethals GRAT 2003" which will mature in August 2008), is1,797,912 shares. There is no economic benefit accruing to Mr. Goethals as a result of thematurity of the Ignace Goethals GRAT 2001. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.